+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Egypt Cancer Diagnostic Market by Product, Technology, Application, End-user, Region, Competition, Forecast & Opportunities, 2028

  • PDF Icon


  • 74 Pages
  • July 2023
  • Region: Egypt
  • TechSci Research
  • ID: 5849426
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Egypt Cancer Diagnostic Market is anticipated to witness a growth of steady CAGR during the forecast period, 2024-2028. This can be ascribed to the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, diabetes, and others, the growing number of private diagnostic centers, increasing lifestyle diseases, and increasing rate of rejuvenation and anti-aging amongst the population. Egypt ranks number 2 in the world in terms of deaths caused by cancer, especially liver cancer. According to Global Cancer Observatory (Egypt), in 2020, around 134,632 new cancer cases were reported in the country, in which males and females accounted for 66,542 and 68,090 cases, respectively 2020.

Cancer diagnostics is a method of identifying different biomarkers, proteins, and some signs that lead to the identification of the presence of a cancerous tumor. Efficient diagnostic testing is used to validate or rule out the existence of illness, monitor the progression of the disease, and schedule & review treatment outcomes. Diagnostic procedures for cancer may include imaging, tumor biopsy, laboratory tests (including tests for tumor markers), endoscopic examination, surgery, or genetic testing. However, the demand for new diagnostic techniques/tools is increasing, which is further expected to drive the growth of the Cancer Diagnostic Market.

The growing prevalence of new cancer cases, rising awareness for cancer screening, the advanced technological advancement with the highest accuracy and precision, and the growing awareness for early detection of cancer amongst the population globally are projected to propel the growth of the market. Additionally, expansion in research & development schemes being initiated by various government institutions, private institutions, and diagnostic imaging centers across the globe is further expected to create lucrative opportunities for the growth of the Cancer Diagnostic Market in the coming years. According to the latest report of the World Health Organization, in 2020, liver cancer deaths in Egypt accounted for 24,512 or 4.57% of total deaths.

The growing number of private diagnostic centers

The number of private diagnostic centers is increasing across the country owing to the rising demand for diagnostic imaging procedures as well as a growing burden on public hospitals due to their limited number of imaging modalities. According to recent developments, in 2021, a company, namely Fujifilm DKH LLP, in a joint venture with Dr. Kutty's Healthcare, opened hospitals and screening centers in the Middle East. Due to these centers, cancer can be diagnosed at an early stage and can be treated easily, and patients can recover smoothly.

Rising Rejuvenation and Early-aging in Population

In Egypt, currently, 74% (~75 million) of the population is under the age of 40 years, and it is expected to increase to 86 million by 2030. Concurrently, only 8% (~7.7 million) of the population is over the age of 60 years, which is expected to increase to 13.8% (~18 million) by the end of 2030. However, 4.6 million of the population is above the age of 65 years, which is expected to increase to 12.3 million by 2030. Therefore, there is an increasing demand for services focusing on rejuvenation and anti-aging, including stem cell therapy, hyperbaric oxygen therapy (HBOT), and other similar services.

Sedative Lifestyle Leads to Cancer

Cancer is caused due to an unhealthy lifestyle. Sedentary behaviors have wide-ranging adverse impacts on the human body, including increased all-cause mortality, cardiovascular disease mortality, cancer risk, and risks of metabolic disorders such as diabetes mellitus, hypertension, and dyslipidemia; musculoskeletal disorders such as arthralgia and osteoporosis, depression, etc. For instance, Egypt has one of the highest prevalence of lifestyle diseases in the world, with approximately 17% of the population over 20 years with diabetes, 32% with obesity, and over 25% suffering from hypertension. According to the Centers for Disease Control and Prevention (CDC), around 15% of adults are physically inactive and do not participate in activities such as running, walking for exercise, or gardening. Therefore, a sedentary lifestyle and lack of physical activity can lead to cancer and thereby propel the growth of Egypt Cancer Diagnostic Market.

Growth in Research & Development

Rapid advancements in research and development (R&D) practices and activities are driving the growth of the market on account of the growing need to develop novel diagnostic solutions for the treatment of different life-threatening diseases. According to World Data Atlas (Egypt), in 2020, R&D expenditure for Egypt was 1 %. Therefore, the R&D expenditure of Egypt increased from 0.2 % in 1,998 to 1 % in 2020, growing at an average annual rate of 9.82%. A recent advancement also includes cancer treatment with immunotherapy, which is anticipated to be significant to the high availability of immunotherapy drugs, and several initiatives are taken by the government and non-government organizations to make diagnostic procedures affordable. This, in turn, supports the growth of Egypt Cancer Diagnostic Market.

Market Segmentation

Egypt Cancer Diagnostic Market can be segmented on the basis of product, technology, application, end user, region, and company. Based on the product, the market can be further segmented into consumables and instruments. Based on technology, the market is further split into IVD testing, imaging, and biopsy. Based on application, the market is further divided into breast cancer, lung cancer, colorectal cancer, and others. Based on end-user, the market is further segmented into hospitals & clinics, diagnostic laboratories, and others.

Company Profiles

Abbott Egypt, Agilent Egypt, Roche Egypt LLC, FUJIFILM Healthcare Middle East S.A.E., Siemens Healthineers Egypt, BioMerieux Egypt, GE Healthcare Egypt, Ortho Clinical Diagnostics, PerkinElmer International C.V., and Epigenomics Egypt, etc. are some of the key players operating in the Egypt Cancer Diagnostic market.

Report Scope

In this report, Egypt Cancer Diagnostic Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cancer Diagnostic Market, By Product:

  • Consumable
  • Instruments

Cancer Diagnostic Market, By Technology:

  • IVD Testing
  • Imaging
  • Biopsy

Cancer Diagnostic Market, By Application:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Cancer Diagnostic Market, By Region:

  • Cairo
  • Qalyubia
  • Alexandria
  • Port Said
  • Giza
  • Suez
  • Rest of Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Egypt Cancer Diagnostic Market.

Available Customizations

With the given market data, the analyst offers customizations according to a company’s specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
4. Overview of Key Market Players
4.1. Overview of Key Regions/Countries
4.2. Overview of Market Drivers, Challenges, Trends
5. Voice of Customer
6. Egypt Cancer Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumable v/s Instruments)
6.2.2. By Technology (IVD Testing, Imaging, Biopsy)
6.2.3. By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others)
6.2.4. By End-user (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.5. By Company (2022)
6.2.6. By Region
6.3. Market Map
6.3.1. By Product
6.3.2. By Technology
6.3.3. By Application
6.3.4. By End-user
6.3.5. By Region
7. Egypt Cancer Diagnostics Consumables Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End-user
8. Egypt Cancer Diagnostics Instruments Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End-user
9. Market Dynamics
9.1. Drivers
9.1.1. Growing number of private diagnostic centres
9.1.2. Rising Rejuvenation and Anti-aging in Population
9.1.3. Sedative Lifestyle Leads to Cancer
9.2. Challenges
9.2.1. Increasing adoption of refurbished diagnostic imaging systems
9.2.2. Limited availability of healthcare staff
9.2.3. Lack of awareness for imaging procedures amongst cancer patients
10. Market Trends & Developments
11. Competitive Landscape
11.1. Business Overview
11.2. Product Offerings
11.3. Recent Developments
11.4. Financials (In Case of Listed Companies)
11.5. Key Personnel
11.5.1. Abbott Egypt
11.5.2. Agilent Egypt
11.5.3. Roche Egypt LLC
11.5.4. FUJIFILM Healthcare Middle East S.A.E.
11.5.5. Siemens Healthineers Egypt
11.5.6. BioMerieux Egypt
11.5.7. GE Healthcare Egypt
11.5.8. Ortho Clinical Diagnostics
11.5.9. PerkinElmer International C.V
11.5.10. Epigenomics Egypt
12. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Egypt
  • Agilent Egypt
  • Roche Egypt LLC
  • FUJIFILM Healthcare Middle East SAE.
  • Siemens Healthineers Egypt
  • BioMerieux Egypt
  • GE Healthcare Egypt
  • Ortho Clinical Diagnostics
  • PerkinElmer International C.V
  • Epigenomics Egypt